November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA     Annals of Int Med
Aug 23, 2025, 16:30

Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA Annals of Int Med

Benjamin Terrier, Professor of Internal Medicine at Cochin Hospital, Paris Cité University, shared a post on X:

“Thrilled to share our latest RCT in EGPA comparing Rituximab Versus Conventional Therapy for Remission Induction, and published in
Annals of Internal Medicine Journal.

-Thanks to all the amazing French Vasculitis Study Group.”

Read the full article here.

Article: Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis: A Randomized Controlled Trial

Authors: Benjamin Terrier, Grégory Pugnet, Claire de Moreuil, Bernard Bonnotte, Ygal Benhamou, Dominique Chauveau, Marie-Charlotte Besse, Pierre Duffau, Nicolas Limal, Antoine Néel, Geoffrey Urbanski, Noémie Jourde-Chiche, Nicolas Martin-Silva, Julien Campagne, Arsène Mekinian, Nicolas Schleinitz, Felix Ackermann, Anne-Laure Fauchais, Antoine Froissart, Thomas Le Gallou, Yurdagul Uzunhan, Jean-François Viallard, Alice Bérezné, Laurent Chiche, Camille Taillé, Guillaume Direz, Cécile-Audrey Durel, Pascal Godmer, Salim Trad, Marc Lambert, Mathilde de Menthon, Thomas Quéméneur, Jacques Cadranel, Pierre Charles, Antoine Dossier, Léa Jilet, Loïc Guillevin, Hendy Abdoul, Xavier Puéchal, and the French Vasculitis Study Group

Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA Annals of Int Med

Stay updated with Hemostasis Today.